Pilot Study to Improve Survivorship Care Related to Fertility and Family-building After Cancer
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cancer
- Sponsor
- Stanford University
- Enrollment
- 20
- Locations
- 1
- Primary Endpoint
- Decisional Conflict Scale (DCS)
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
The goal of this research is to explore how a patient decision aid tool (website) given to patients prior to their survivorship care visits, may impact patient-provider communication about fertility and family-building after cancer; and assess the impact of using the tool on patient reported outcomes. The overall purpose of this research is to improve survivorship care by establishing a multi-disciplinary approach to managing cancer and fertility issues and prompt early referral to supportive and medical care resources.
Detailed Description
Objective 1: Establish feasibility and acceptability of conducting research with YA-F cancer survivors at the Stanford Cancer Institute (SCI) and Lucile Packard Children's Hospital (LPCH). Hypothesis 1: Study procedures will be feasible in the given timeframe and acceptable to patients, as evidence by recruitment, enrollment, and completion rates and participant feedback. Objective 2: Evaluate the impact of using the tool as a part of survivorship care on patient reported outcomes (PROs; i.e., information needs, fertility distress, decision-making uncertainty, and satisfaction with care). Hypothesis 2: In a single-arm pilot study (N=20), use of the decision aid tool will lead to improvements in fertility distress, decision-making uncertainty, and satisfaction with care.
Investigators
Eligibility Criteria
Inclusion Criteria
- •completed cancer treatment at least 6-months prior, excluding long-term adjuvant or maintenance therapies
- •report an interest in discussing fertility/family-building with a provider
- •understands verbal and written English
- •access to the Internet and use of a computer, tablet, or smartphone
- •has a scheduled cancer survivorship visit within the study time frame
Exclusion Criteria
- •Prior hospitalization for a mental disorder or history of psychosis
- •Note: Survivors on adjuvant maintenance or endocrine treatment, such as tamoxifen, will not be excluded because clinical guidelines allow treatment delay or hiatus to accommodate fertility
Outcomes
Primary Outcomes
Decisional Conflict Scale (DCS)
Time Frame: 6 weeks
The Decisional Conflict Scale (DCS) is a validated survey that assesses personal uncertainty in making healthcare decisions; modifiable factors contributing to uncertainty; and the quality of the decision made. It is reliable and responsive to change, and the most widely used measure of decision-making quality. The survey has 16 questions, with responses on a 5-point scale ranging from "strongly agree" (1) to "strongly disagree" (5). Total scores range from 16 to 80, with higher scores indicating greater uncertainty (worse outcome). The outcome will be reported as the mean difference from baseline to 4-week and 6-week follow-up time points, with standard deviation.
Secondary Outcomes
- Unmet Fertility Information(6 weeks)
- Reproductive Concerns After Cancer (RCAC) Scale(6 weeks)
- COMRADE(6 weeks)